Going anti-Viral  By  cover art

Going anti-Viral

By: Going Anti-Viral
  • Summary

  • Introducing Going anti-Viral, the podcast of the IAS–USA, a professional continuing medical education organization focused on HIV and other viral diseases. I’m Dr Michael Saag, professor emeritus of medicine and infectious diseases at the University of Alabama at Birmingham and volunteer member of the IAS–USA Board of Directors.
    Join us as we interview experts in viral medicine about their area of specialty and current developments in the field. Other episodes are drawn from the IAS-USA vast catalogue of panel discussions, Dialogues, and various meetings and conferences.
    Going anti-Viral is a podcast series for clinicians, produced by the International Antiviral Society–USA. The IAS–USA is a not-for-profit professional organization committed to improving the treatment, care, and quality of life for people with or at risk for HIV or other viral infections and their complications through balanced education and information. This podcast is intended as a technical source of information for specialists in this field, but we hope anyone listening will enjoy learning more about the state of modern medicine around viral infections and their consequences.

    © 2024 Going anti-Viral
    Show more Show less
activate_primeday_promo_in_buybox_DT
Episodes
  • Episode 20 - The Impact of GLP-1 Receptor Agonists with Dr Suman Srinivasa
    Jul 2 2024

    Episode 20 - The Impact of GLP-1 Receptor Agonists with Dr Suman Srinivasa


    In this episode of Going anti-Viral, Dr Michael Saag speaks with Dr Suman Srinivasa from Harvard Medical School about the impact of GLP-1 receptor agonists on diabetes and obesity. They discuss the mechanisms, benefits, and current and potential applications, including their use by people with HIV. The episode also highlights future prospects and challenges, including access to medication.


    00:00 Introduction


    01:42 Understanding GLP-1 Receptor Agonists


    03:19 Mechanisms and Benefits of GLP-1 Receptor Agonists


    05:34 Clinical Applications and Insurance Challenges


    09:56 GLP-1 Receptor Agonists in HIV Patients


    15:50 Future Prospects and Broader Applications


    23:37 Closing Remarks

    __________________________________________________

    Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections.

    Going anti-Viral’s host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences.

    Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.

    Follow Going anti-Viral on:
    Apple Podcasts
    YouTube
    Instagram
    TikTok
    ...

    Show more Show less
    27 mins
  • Episode 19 - Latest Update on Urgent Viral Outbreaks Recorded June 11, 2024
    Jun 18 2024

    This episode of Going anti-Viral features an IAS–USA Dialogue titled "Latest Update on Urgent Viral Outbreaks," which is a panel discussion held on June 11, 2024.

    Dr Paul A. Volberding from the University of California San Francisco serves as moderator and welcomes three distinguished panelists: Dr Carlos del Rio from Emory University, Yvonne Maldonado from Stanford University, and Dr Peter Chin-Hong from the University of California San Francisco. The episode covers various pressing topics, including updates on COVID-19, avian flu, MPOX, measles, and other viral diseases. Discussions touch on vaccines, their effectiveness, public health approaches, and current research.


    00:00 Introduction to Going Antiviral Podcast


    01:21 COVID-19 Current Issues and Personal Experiences


    06:11 Long COVID and Paxlovid Study


    07:59 Global Perspective on COVID-19


    13:59 COVID-19 Vaccination Updates


    23:52 Avian Flu: Current Concerns and Insights


    29:15 The Threat of Avian Flu


    29:46 Understanding H5N2 and Its Impact


    33:09 The Ongoing MPOX Outbreak


    37:02 Global Public Health Challenges


    49:51 Travel Vaccines and Precautions


    56:31 The Importance of RSV Vaccination


    58:14 Concluding Remarks and Resources

    __________________________________________________

    Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections.

    Going anti-Viral’s host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences.

    Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.

    Follow Going anti-Viral on:
    Apple Podcasts
    YouTube
    Instagram
    TikTok
    ...

    Show more Show less
    59 mins
  • Episode 18 - CROI 2024 Insights: Future Prospects of HIV Management and Cardiovascular Health with Dr Todd Brown
    Jun 4 2024

    Episode 18 - CROI 2024 Insights: Future Prospects of HIV Management and Cardiovascular Health with Dr Todd Brown Recorded May 3, 2024


    This episode discusses the evolving landscape of HIV-related metabolic complications and cardiovascular health. Dr Michael Saag and Dr Todd Brown cover insights from CROI 2024, key studies on blood pressure management, the cardiovascular benefits of statins, and the promising role of GLP-1 receptor agonists in treating diabetes, obesity, and cardiovascular disease in people with HIV.



    00:00 Introduction


    01:56 Blood Pressure Management in HIV


    09:56 The Impact of Statins on Cardiovascular Health


    18:07 The Revolutionary Role of GLP-1 Receptor Agonists in HIV Management


    27:01 Looking Ahead: The Future of HIV Treatment and Management


    29:21 Closing Remarks and Future Directions

    __________________________________________________

    Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections.

    Going anti-Viral’s host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences.

    Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.

    Follow Going anti-Viral on:
    Apple Podcasts
    YouTube
    Instagram
    TikTok
    ...

    Show more Show less
    31 mins

What listeners say about Going anti-Viral

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.